Business Context and Reporting Period
Company: Palatin Technologies, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 12, 2025
Event: Closing of the exercise of the over-allotment option in connection with a firm commitment public offering.
Key Financial Metrics
This filing reports on capital raising activities rather than operational performance. Specific metrics include:
- Additional Gross Proceeds: Approximately $2.37 million from the over-allotment exercise.
- Total Gross Proceeds: Approximately $18.2 million after including the over-allotment.
- Offering Price: $6.50 per share for common stock and pre-funded warrants.
- Securities Issued:
- 280,615 shares of Common Stock.
- Pre-funded warrants to purchase 84,000 shares of Common Stock.
- Series J Warrants to purchase up to 364,615 shares (Exercise Price: $6.50).
- Series K Warrants to purchase up to 364,615 shares (Exercise Price: $8.125).
Note: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions.
Material Changes
The primary material change is the increase in gross proceeds from the public offering due to the full exercise of the underwriters' over-allotment option. This transaction increased the total capital raised to approximately $18.2 million.
Guidance, Outlook, and Risks
Management Commentary: The Company announced the sale of the securities via a press release incorporated by reference. The transaction was executed with underwriters A.G.P./Alliance Global Partners and Laidlaw & Company (UK) Ltd.
Risks and Contingencies: The filing does not explicitly detail new risks or contingencies beyond the standard disclosure of underwriting fees and offering expenses payable by the Company. No forward-looking guidance or outlook is provided in this specific 8-K text.
Investor Verification Checklist
- Verify the final net proceeds after deducting underwriting fees and offering expenses.
- Review the attached press release (Exhibit 99.1) for details on the intended use of the $18.2 million in gross proceeds.
- Confirm the dilution impact of the 280,615 new shares and the potential future dilution from 729,230 warrant shares (Series J and K).
- Check the Company's latest 10-Q or 10-K for current cash balances and liquidity status to assess the impact of this capital raise.